Editorial Board

Juan Alderuccio, MD, University of Miami Miami, FL (Lymphoma)
Jennifer Amengual, MD, Columbia University Irving Medical Center, New York, NY (Lymphoma)
Benjamin Barwick, PhD, Emory University, Atlanta, GA (ALL/CLL/Lymphoma/Myeloma)
Kapil Bhalla, MD, University of Texas MD Anderson Cancer Center, Houston, TX (AML/MDS/MPN) Elizabeth Brem, MD, UCI Health, Orange, CA (Lymphoma)
Marta Chesi, PhD, Mayo Clinic, Phoenix, AZ (Myeloma)
Wee Jo Chng, MBBS, PhD, FRCP, FRCPath, National University of Singapore, Singapore, Singapore (ALL/CLL/Lymphoma/Myeloma)
Terry Fry, MD, Children’s Hospital Colorado, Aurora, CO (CAR-T Cells)
Varsha Gandhi, PhD, FRACP, FRCPA, University of Texas MD Anderson Cancer Center, Houston, TX (ALL/CLL/Lymphoma/Myeloma)
Lucy Godley, MD, PhD, Northwestern University, Evanston, IL (AML/MDS/MPN)
Michael Green, PhD, University of Texas MD Anderson Cancer Center, Houston, TX (ALL/CLL/Lymphoma/Myeloma)
Olga Guryonova, MD, PhD, University of Florida, Gainesville, FL (AML/MDS/MPN)
Gabriela Hobbs, MD, Massachusetts General Hospital, Boston, MA (MPN/CML/Clinical Trials)
Xiaojun Huang, BMed, BEng, MMed, PhD, The Chinese University of Hong Kong, Hong Kong, China (MM/Lymphoma/Leukemia)
Vania Hungria, MD, PhD, Santa Casa Medical School, San Paulo, Brazil (MM/Amyloidosis/Monoclonal Gammopathy)
Shai Izraeli, PhD, Schneider Children's Medical Center, Petah Tikva, Israel (ALL/CLL/Lymphoma/Myeloma)
Ricky Johnstone, MD, Peter MacCallum Cancer Centre, Melbourne, Australia (ALL/CLL/Lymphoma/Myeloma)
Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, Bronx, NY (MDS)
Megan Lim, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, New York (ALL/CLL/Lymphoma/Myeloma)
Tara Lin, MD, University of Kansas, Kansas City, KS (AML/MDS/MPN)
Daniel Link, MD, Washington University School of Medicine, St. Louis, MO (AML/MDS/MPN)
Michael Lüebbert, PhD, University of Freiburg, Freiburg, Germany (AML/MDS)
José Ángel Martínez Climent, MD, PhD, Cima Universidad de Navarra, Pamplona, Spain (Lymphoma/ MM)
Heike Pahl, MD, PhD, University Hospital Freiburg, Freiburg, Germany (AML/MDS)
Samir Parekh, MD, Mount Sinai, New York, NY (Multiple Myeloma)
Charlotte Pawlyn, PhD, Institute of Cancer Research, London, UK (ALL/CLL/Lymphoma/Myeloma)
Alexander Perl, MD, PhD, University of Pennsylvania, Philadelphia, PA (Leukemia)
Yana Pikman, MD, PhD, Dana Farber Cancer Institute, Boston, MA (ALL/CLL/Lymphoma/Myeloma)
Ruibao Ren, MD, PhD, Shanghai Jiao Tong University, Shanghai, China (Leukemia/Lymphoma)
Valeria Santini, MD, University of Florence, Florence, Italy (AML/MDS/PNH)
Clementine Sarkozy, MD, PhD, Institut Curie, Paris, France (Non Hodgkin Lymphoma/Hodgkin Lymphoma/ CLL)
Liran Shlush, MD, PhD, The Weizmann Institute of Science, Rehovot, Israel (Myeloma Malignancies, Hematopoiesis/ Molecular Diagnostics)
Sonali Smith, MD, University of Chicago, Chicago, IL (ALL/CLL/Lymphoma/Myeloma)
Christian Steidl, MD, University of British Columbia, Vancover, BC Canada (Lymphoma Pathogenesis/ Tumor Microenvironment Biology and Genomics)
Rodger Tiedemann, PhD, FRACP, FRCPA, University of Toronto, Toronto, Canada (ALL/CLL/Lymphoma/Myeloma)
Aaron Viny, MD, MS, Columbia University, New York, NY (AML/MDS/MPN)
Justin Watts, MD, University of Miami, Miami, FL (AML/MDS/MPN)
Jennifer Woyach, MD, The Ohio State University, Columbus, OH (CLL: clinical & translational)